INFLAMMATION, SUBSTANCE USE, SYMPTOMS, AND COGNITION IN PHASE 1 OF THE CLINICAL ANTIPSYCHOTIC TRIALS OF INTERVENTION EFFECTIVENESS STUDY

被引：0
|
作者：
Miller, Brian [1 ]
Buckley, Peter [1 ]
McEvoy, Joseph [1 ]
机构：
[1] Augusta Univ, Augusta, GA USA
来源：
SCHIZOPHRENIA BULLETIN | 2017年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
175.3
引用
收藏
页码：S89 / S90
页数：2
相关论文
共 50 条
  • [31] Time to All-Cause Treatment Discontinuation as the Primary Outcome in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Study
    Davis, Sonia M.
    Stroup, T. Scott
    Koch, Gary G.
    Davis, Clarence E.
    Rosenheck, Robert A.
    Lieberman, Jeffrey A.
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2011, 3 (02): : 253 - 265
  • [32] Baseline neurocognitive assessment of 1364 patients with schizophrenia in the clinical antipsychotic trials for intervention effectiveness (CATIE) project
    Keefe, R
    Bilder, RM
    Palmer, B
    Harvey, PD
    Davis, S
    McEvoy, J
    Golberg, T
    Gold, J
    Green, MF
    Swartz, MS
    Stroup, S
    Rosenheck, R
    Perkins, D
    Meltzer, H
    Lieberman, JA
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 79S - 79S
  • [33] The relationship between suicide and violence in schizophrenia: Analysis of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) dataset
    Witt, Katrina
    Hawton, Keith
    Fazel, Seena
    SCHIZOPHRENIA RESEARCH, 2014, 154 (1-3) : 61 - 67
  • [34] Prognostic Subgroups for Remission, Response, and Treatment Continuation in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Trial
    Jakubovski, Ewgeni
    Carlson, Jon P.
    Bloch, Michael H.
    JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (11) : 1535 - 1545
  • [35] Estimating the optimal dynamic antipsychotic treatment regime: evidence from the sequential multiple-assignment randomized Clinical Antipsychotic Trials of Intervention and Effectiveness schizophrenia study
    Shortreed, Susan M.
    Moodie, Erica E. M.
    JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 2012, 61 : 577 - 599
  • [36] Baseline neurocognitive assessment of 1364 patients with schizophrenia in the clinical antipsychotic trials for intervention effectiveness (CATIE) project
    Keefe, R
    Bilder, RM
    Harvey, PD
    Davis, S
    Palmer, B
    McEvoy, JP
    Goldberg, TE
    Gold, JM
    Green, MR
    Swartz, M
    Stroup, S
    Rosenheck, R
    Perkins, DO
    Meltzer, HY
    Miller, D
    Canive, J
    Walker, TM
    Lieberman, JA
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 361 - 362
  • [37] Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: Development, methodology, and rationale
    Keefe, RSE
    Mohs, RC
    Bilder, RM
    Harvey, PD
    Green, MF
    Meltzer, HY
    Gold, JM
    Sano, M
    SCHIZOPHRENIA BULLETIN, 2003, 29 (01) : 45 - 55
  • [38] National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) - Alzheimer disease trial methodology
    Schneider, LS
    Tariot, PN
    Lyketsos, CG
    Dagerman, KS
    Davis, KL
    Davis, S
    Hsiao, JK
    Jeste, DV
    Katz, IR
    Olin, JT
    Pollock, BG
    Rabins, PV
    Rosenheck, RA
    Small, GW
    Lebowitz, B
    Lieberman, JA
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2001, 9 (04) : 346 - 360
  • [39] Substance Use Within Trials of Psychological Interventions for Psychosis: Sample Inclusion, Secondary Measures, and Intervention Effectiveness
    Halsall, Lauren
    Ushakova, Anastasia
    Jones, Steven
    Chowdhury, Samin
    Goodwin, Laura
    SCHIZOPHRENIA BULLETIN, 2024, 50 (06) : 1489 - 1498
  • [40] Statistical approaches to effectiveness measurement and outcome-driven re-randomizations in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) studies
    Davis, SM
    Koch, GG
    Davis, CE
    LaVange, LM
    SCHIZOPHRENIA BULLETIN, 2003, 29 (01) : 73 - 80
12345